BioHarvest Sciences Inc. ... (BHST)
| Bid | 4 |
| Market Cap | 88.37M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -1.28 |
| PE Ratio (ttm) | -3.98 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 6.06 |
| Volume | 8,424 |
| Avg. Volume (20D) | 7,043 |
| Open | 5.30 |
| Previous Close | 5.18 |
| Day's Range | 5.02 - 5.30 |
| 52-Week Range | 0.00 - 7.38 |
| Beta | 1.49 |
About BHST
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contra...
Analyst Forecast
According to 2 analyst ratings, the average rating for BHST stock is "Buy." The 12-month stock price forecast is $13, which is an increase of 154.90% from the latest price.
1 month ago · proactiveinvestors.com
BioHarvest Sciences appoints veteran technology leader to board of directorsBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) has announced the appointment of seasoned technology executive Sharon Malka as an independent director of the company. Malka brings extensive leadershi...
1 month ago · newsfilecorp.com
BioHarvest Announces Appointment of Sharon Malka to Board of DirectorsVeteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the Board Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 22, 2025) - BioHarvest Sc...
1 month ago · proactiveinvestors.com
BioHarvest Sciences positioned for ‘legacy year' in 2025, building on momentum with new innovations and strategic collaborationsBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) is poised to capitalize on key trends shaping the health and wellness industry in 2025, including a growing focus on sustainability, longevity-driven h...
1 month ago · proactiveinvestors.com
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growthBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) CEO Ilan Sobel has reflected on 2024 as “a year of transformation and growth” for the company. In a letter to shareholders, Sobel highlighted the launc...
1 month ago · newsfilecorp.com
BioHarvest Issues Shareholder Letter and Provides Corporate UpdateVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc. , (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pione...
2 months ago · proactiveinvestors.com
BioHarvest Sciences CEO discusses Tate & Lyle partnership - ICYMIBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) this week announced a significant move for the company, a partnership with Tate & Lyle to develop plant-based sweeteners. The collaboration aims to cre...
2 months ago · proactiveinvestors.com
BioHarvest Sciences partners with Tate & Lyle to advance plant-based sweetenersBioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) announced it has partnered with Tate & Lyle PLC (LSE:TATE) to develop proprietary plant-based molecules for food and beverage ingredients. The partners...
